SABS (sabbiotherapeutics.com) Volume dana dhuwit perusahaan

Logo grafis SAB Biotherapeutics Inc (SABS)

The cash reserve amount demonstrates liquidity dynamics, where the 0.10 mark serves as a key metric. Primary threats are linked to uncertainty regarding the approval timelines for innovative antibody production technology and a dependence on government subsidies. SAB Biotherapeutics (SABS) is developing immune pharmaceuticals through government alliances, yet high scaling costs for diabetes treatment force the company to rely on venture capital.

SABS - Aset likuid perusahaan SAB Biotherapeutics, Inc ing rentang 04.07.2022 - 21.11.2026

Rincian metrik komprehensif lan analitis SAB Biotherapeutics, Inc. (SABS)

Pambiji fundamental:SAB Biotherapeutics Inc.
Sampel barang sabbiotherapeutics.com

A comparative liquidity analysis allows an investor to assess business resilience against rising borrowing costs through the volume of available cash and cash equivalents. For SAB Biotherapeutics (SABS), this metric determines the survival horizon until the stage of industrial production and validation of diabetes therapy; therefore, changes in the cash balance serve as an indicator of the company's ability to fund clinical trials without the emergency procurement of expensive debt.

Pesaing SAB Biotherapeutics (SABS)

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|kalvista.com - Volume dana dhuwit perusahaan|SEPN (septerna.com) - Dhuwit awis lan setara dhuwit awis perusahaan|PVLA (Pieris Pharmaceuticals) - Dhuwit awis perusahaan|Savara - Sisa dhuwit perusahaan|RIGL (Rigel Corp) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan AnaptysBio Corp|Dana dhuwit perusahaan astriatx.com (ATXS)|Dhuwit awis perusahaan enGene ENGN|Dana dhuwit perusahaan RAPT Therapeutics, Inc. RAPT|JBIO - Dhuwit awis perusahaan|Aclaris Therapeutics Inc. - Volume dana dhuwit perusahaan|KYTX - Volume dana dhuwit perusahaan|TLSA (Tiziana Life Sciences PLC) - Dhuwit awis perusahaan|cabalettabio.com (CABA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Ventyx Biosciences|THTX (Theratechnologies) - Gunggung dana dhuwit perusahaan|Dhuwit awis perusahaan AVTX (Avalo Therapeutics Inc.)|Dana dhuwit perusahaan ELDN (Eledon)|Volume dana dhuwit perusahaan AGEN (Agenus, Inc)|Aset likuid perusahaan climbbio.com (CLYM)|zurabio.com - Volume dana dhuwit perusahaan|ATYR - Volume dana dhuwit perusahaan|ADAG: Volume dana dhuwit perusahaan|Ikena Oncology, Inc. (IMA) - Volume dana dhuwit perusahaan|STTK (Shattuck Therapeutics) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan equilliumbio.com EQ|Volume dana dhuwit perusahaan CNTB|IMUX - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Atara Biotherapeutics ATRA|Aset likuid perusahaan InflaRx N.V. (IFRX)|XFOR: Dhuwit awis perusahaan|adicetbio.com (ACET) - Dhuwit awis perusahaan|CELU: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan INmune Bio (INMB)|Dana dhuwit perusahaan Barinthus Bio|Dhuwit awis lan setara dhuwit awis perusahaan KZR (Kezar Life Sciences, Inc)|Dana dhuwit perusahaan Akari Therapeutics Plc (AKTX)|Dhuwit awis perusahaan Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Dhuwit awis perusahaan|GeoVax Labs (GOVX) - Cadangan dhuwit perusahaan|edesabiotech.com - Volume dana dhuwit perusahaan|Aset likuid perusahaan iBio Corp IBIO|CARM: Volume dana dhuwit perusahaan|xtlbio.com (XTLB) - Volume dana dhuwit perusahaan|BOLT (Bolt Biotherapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan HCW Biologics (HCWB)|Dhuwit awis perusahaan APVO (Aptevo Therapeutics)|AIM - Cadangan dhuwit perusahaan|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD